Do negative diagnostic 131-I and 124-I scans exclude 131-I as a treatment option in patients with positive thyroglobulin levels?

被引：0
|
作者：
Chennupati, S. [1 ]
Van Nostrand, Douglas [1 ]
Bandaru, Varalakshmi [1 ]
Moreau, S. [1 ]
机构：
[1] Washington Hosp Ctr, Div Nucl Med, Washington, DC 20010 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2009年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1668
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The use of 131-I in syringomyelia treatment
    Grushka, G.
    Afanasieva, N.
    Mazkova, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S207 - S207
  • [2] Preablation 131-I Scans With SPECT/CT Contribute to Thyroid Cancer Risk Stratification and 131-I Therapy Planning
    Avram, Anca M.
    Esfandiari, Nazanene H.
    Wong, Ka Kit
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (05): : 1895 - 1902
  • [3] Dosimetric evaluation in patient with metastatic differentiated thyroid cancer by the use of 124-I and 131-I: a case report
    Rossi, G.
    Fattori, S.
    Camarda, M.
    D'Avenia, P.
    Di Nicola, E.
    Montani, L.
    Capoccetti, F.
    Criscuoli, B.
    Barucca, S.
    Brianzoni, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S321 - S321
  • [4] Increase of thyroglobulin after 131-I treatment is related to the absorbed dose.
    Bourgeois, P. L. O. C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S327 - S327
  • [5] Graves' ophthalmopathy in patients treated with radioiodine 131-I
    Baldys-Waligorska, Agata
    Golkowski, Filip
    Kusnierz-Cabala, Beata
    Buziak-Bereza, Monika
    Hubalewska-Dydejczyk, Alicja
    ENDOKRYNOLOGIA POLSKA, 2011, 62 (03) : 214 - 219
  • [6] Usefullness of ablation dose of 131-I in patients with differentiated thyroid cancer with high 131-I uptake due to subtotal thyroidectomy
    Prassopoulos, V
    Elias, J
    Sifakis, N
    Alevizaki, M
    Gerali, S
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1215 - 1215
  • [7] Treatment of malignant pheochromocytomas with 131-I metaiodobenzylguanidine and chemotherapy
    Sisson, JC
    Shapiro, B
    Shulkin, BL
    Urba, S
    Zempel, S
    Spaulding, S
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (04): : 364 - 370
  • [8] I-131 therapy in differentiated thyroid carcinoma patients with high thyroglobulin levels despite negative diagnostic I-131 scans
    Akgun, A.
    Yazici, B.
    Erdim, O.
    Ozcan, Z.
    Ozkilic, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S330 - S330
  • [9] Efficacy of 131-I treatment in patients with Graves-Basedow disease
    Saura, A
    Hervás, I
    González-Cabezas, P
    Rivas, A
    Alonso, J
    Bello, P
    Mateo, A
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1181 - 1181
  • [10] Do Negative 124I Pretherapy Positron Emission Tomography Scans in Patients with Elevated Serum Thyroglobulin Levels Predict Negative 131I Posttherapy Scans?
    Khorjekar, Gauri R.
    Van Nostrand, Douglas
    Garcia, Carlos
    O'Neil, Jeffrey
    Moreau, Shari
    Atkins, Francis B.
    Mete, Mihriye
    Orquiza, Michael H.
    Burman, Kenneth
    Wartofsky, Leonard
    THYROID, 2014, 24 (09) : 1394 - 1399
12345